Oh JT - Search Results

1

The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.

Sauve K, Watson A, Oh JT, Swift S, Vila-Farres X, Abdelhady W, Xiong YQ, LeHoux D, Woodnutt G, Bayer AS, Schuch R. Sauve K, et al. Among authors: oh jt. J Infect Dis. 2024 Aug 16;230(2):309-318. doi: 10.1093/infdis/jiae027. J Infect Dis. 2024. PMID: 38366561

2

Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.

Oh JT, Cassino C, Schuch R. Oh JT, et al. Antimicrob Agents Chemother. 2019 May 24;63(6):e02616-18. doi: 10.1128/AAC.02616-18. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30936103 Free PMC article.

3

Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis.

Watson A, Oh JT, Sauve K, Bradford PA, Cassino C, Schuch R. Watson A, et al. Among authors: oh jt. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01078-19. doi: 10.1128/AAC.01078-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31332073 Free PMC article.

4

In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017.

Traczewski M, Oh J, Cassino C, Schuch R. Traczewski M, et al. Diagn Microbiol Infect Dis. 2019 Dec;95(4):114879. doi: 10.1016/j.diagmicrobio.2019.114879. Epub 2019 Aug 1. Diagn Microbiol Infect Dis. 2019. PMID: 31466875

5

The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics.

Oh J, Warner M, Ambler JE, Schuch R. Oh J, et al. Microbiol Spectr. 2023 Mar 2;11(2):e0526122. doi: 10.1128/spectrum.05261-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36862002 Free PMC article.

6

Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase.

Vila-Farres X, Sauve K, Oh J, Swift S, DeJonge B, Ambler JE, Schuch R. Vila-Farres X, et al. Microbiol Spectr. 2023 Aug 10;11(5):e0190623. doi: 10.1128/spectrum.01906-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37561151 Free PMC article.

7

Development of a Broth Microdilution Method for Exebacase Susceptibility Testing.

Oh JT, Ambler JE, Cassino C, Schuch R. Oh JT, et al. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0258720. doi: 10.1128/AAC.02587-20. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33903102 Free PMC article.

8

Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing".

Oh JT, Ambler JE, Cassino C, Schuch R. Oh JT, et al. Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0165821. doi: 10.1128/AAC.01658-21. Epub 2021 Sep 17. Antimicrob Agents Chemother. 2021. PMID: 34533411 Free PMC article. No abstract available.

9

Optimizing dielectric, mechanical, and thermal properties of epoxy resin through molecular design for multifunctional performance.

Deng Y, Wong YW, Teh LKY, Wang Q, Sun W, Chern WK, Oh JT, Chen Z. Deng Y, et al. Among authors: oh jt. Mater Horiz. 2024 Dec 2. doi: 10.1039/d4mh01414f. Online ahead of print. Mater Horiz. 2024. PMID: 39620247

10

Unravelling the role of filler surface wettability in long-term mechanical and dielectric properties of epoxy resin composites under hygrothermal aging.

Deng Y, Wang Q, Pan Z, Lv Z, Chern WK, Oh JT, Chen Z. Deng Y, et al. Among authors: oh jt. J Colloid Interface Sci. 2024 Nov 26;682:50-59. doi: 10.1016/j.jcis.2024.11.186. Online ahead of print. J Colloid Interface Sci. 2024. PMID: 39612763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters